102 related articles for article (PubMed ID: 5441073)
1. N-demethylation the antineoplastic agent4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide by rats and man.
Skibba JL; Beal DD; Ramirez G; Bryan GT
Cancer Res; 1970 Jan; 30(1):147-50. PubMed ID: 5441073
[No Abstract] [Full Text] [Related]
2. Disposition of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide, a new antitumor agent.
Housholder GE; Loo TL
J Pharmacol Exp Ther; 1971 Nov; 179(2):386-95. PubMed ID: 5133607
[No Abstract] [Full Text] [Related]
3. Metabolism of 4(5)-(3,3-dimethyl-1-triazeno)-imidazole-5(4)-carboxamide to 4(5)-aminoimidazole-5(4)-carboxamide in man.
Skibba JL; Ramirez G; Beal DD; Bryan GT
Biochem Pharmacol; 1970 Jun; 19(6):2043-51. PubMed ID: 5513972
[No Abstract] [Full Text] [Related]
4. Microsomal metabolism of triazenylimidazoles.
Hill DL
Cancer Res; 1975 Nov; 35(11 Pt 1):3106-10. PubMed ID: 241485
[TBL] [Abstract][Full Text] [Related]
5. Fate of the ring moiety of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide in mammalian cells.
Saunders PP; Chao LY
Cancer Res; 1974 Oct; 34(10):2464-9. PubMed ID: 4472112
[No Abstract] [Full Text] [Related]
6. Metabolism of dacarbazine by rat liver microsomes contribution of CYP1A enzymes to dacarbazine N-demethylation.
Yamagata S; Ohmori S; Suzuki N; Yoshino M; Hino M; Ishii I; Kitada M
Drug Metab Dispos; 1998 Apr; 26(4):379-82. PubMed ID: 9531528
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in human and animal tumor tissue.
Mizuno NS; Humphrey EW
Cancer Chemother Rep; 1972 Aug; 56(4):465-72. PubMed ID: 5081589
[No Abstract] [Full Text] [Related]
8. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
9. Elevated inary excretion of 4-aminoimidazole-5-carboxamide in patients after intravenous injection of 4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide.
Housholder GE; Loo TL
Life Sci; 1969 May; 8(9):533-6. PubMed ID: 5791705
[No Abstract] [Full Text] [Related]
10. Activity course of amidopyrine-N-demethylation by 9000 x g-liver supernatant of weanling and adult rats of both sexes after administration of carbon tetrachloride.
Klinger W
Acta Biol Med Ger; 1973; 30(1):133-7. PubMed ID: 4736051
[No Abstract] [Full Text] [Related]
11. N-glucuronidation reactions. II. Relative N-glucuronidation reactivity of methylbiphenyl tetrazole, methylbiphenyl triazole, and methylbiphenyl imidazole in rat, monkey, and human hepatic microsomes.
Huskey SW; Doss GA; Miller RR; Schoen WR; Chiu SH
Drug Metab Dispos; 1994; 22(4):651-8. PubMed ID: 7956743
[TBL] [Abstract][Full Text] [Related]
12. Adaptation of a colorimetric determination of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (NSC-45388) and 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) to blood.
Field RB; Hoffman G; Waravdekar VS; Kline I
Cancer Chemother Rep; 1969 Jun; 53(3):199-202. PubMed ID: 4980814
[No Abstract] [Full Text] [Related]
13. Effects of alpha-carbon substituents on the N-demethylation of N-methyl-2-phenethylamines by rat liver microsomes.
Duncan JD; Hallström G; Paulsen-Sörman U; Lindeke B; Cho AK
Drug Metab Dispos; 1983; 11(1):15-20. PubMed ID: 6132789
[TBL] [Abstract][Full Text] [Related]
14. Modification of benzo(a)pyrene metabolism in hepatic microsomes from untreated and induced rats by imidazole derivatives which inhibit monooxygenase activity and enhance epoxide hydrolase activity.
James MO; Little PJ
Drug Metab Dispos; 1983; 11(4):350-4. PubMed ID: 6137342
[TBL] [Abstract][Full Text] [Related]
15. Observations on the "in vitro" oxidative N-demethylation of 4-(3, 3-dimethyl-1-triazeno)-imidazole-5-carboxamide (DIC, NSC 45388).
Giraldi T; Nisi C; Sava G
Pharmacol Res Commun; 1976 Feb; 8(1):25-9. PubMed ID: 1026951
[No Abstract] [Full Text] [Related]
16. Mechanism of action of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide in mammalian cells in culture.
Gerulath AH; Loo TL
Biochem Pharmacol; 1972 Sep; 21(17):2335-43. PubMed ID: 4675028
[No Abstract] [Full Text] [Related]
17. The physiological disposition of the carcinostatic imidazole-4 (or 5)-carboxamide, 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno] (NSC 82196) (imidazole mustard) in mice and dogs.
Vogel CL; Denham C; Waalkes TP; DeVita VT
Cancer Res; 1970 Jun; 30(6):1651-7. PubMed ID: 5457935
[No Abstract] [Full Text] [Related]
18. N-demethylation of the antineoplastic agent hexamethylmelamine by rats and man.
Worzalla JF; Johnson BM; Ramirez G; Bryan GT
Cancer Res; 1973 Nov; 33(11):2810-5. PubMed ID: 4748436
[No Abstract] [Full Text] [Related]
19. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
Szakács T; Veres Z; Vereczkey L
Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
[TBL] [Abstract][Full Text] [Related]
20. Hepatic microsomal metabolism of CCL4 after pretreatment with chlordecone, mirex, or phenobarbital in male rats.
Klingensmith JS; Mehendale HM
Drug Metab Dispos; 1983; 11(4):329-34. PubMed ID: 6193935
[No Abstract] [Full Text] [Related]
[Next] [New Search]
